Assessing IV fluids to prevent pancreatitis after ERCP

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the relationship between peri-procedural intravenous fluid administration and the risk of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. It aims to evaluate short-term aggressive hydration regimens that are practical for outpatient settings, focusing on fluid type, volume, and timing. By analyzing these factors, the study seeks to identify effective strategies to reduce the incidence of post-ERCP pancreatitis, which is a significant adverse event associated with the procedure.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subject referred for ERCP, regardless of indication;
* Subject age 18 years or older;
* Subject able to give informed consent to involvement be included.

Exclusion Criteria:

* Subject has a standard contraindication to ERCP;
* Subject or surrogate unable or unwilling to provide informed consent;
* Subject age \< 18 years.

Where it's running

• Peter Lougheed Hospital
  Calgary, Alberta, Canada Recruiting

Study contacts

• Principal investigator: Nauzer Forbes, MD MSc — University of Calgary
• Study coordinator: Nauzer Forbes, MD MSc
• Email: nauzer.forbes@ucalgary.ca
• Phone: 403-592-5089

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Biomechanical Factors During ERCP for Digestive Specialists

  This study tests how ERCP practitioners experience biomechanical stress during the procedure to see if adjustments to equipment or setup can reduce strain.

  Recruiting Centre Hospitalier Universitaire, Amiens · Amiens, Picardie · NCT07691580

• Early versus late laparoscopic gallbladder removal after clearing common bile duct stones with ERCP

  This trial will test whether having your gallbladder removed soon after ERCP or waiting longer gives better outcomes for people who had stones cleared from their common bile duct.

  Recruiting Khyber Teaching Hospital · Peshawar, Khyberpukhtunkhwa · NCT07130864

• Indomethacin vs diclofenac to prevent pancreatitis after ERCP

  This trial tests whether a single 100 mg rectal dose of indomethacin or diclofenac given before ERCP better prevents post-ERCP pancreatitis in adults with a native papilla.

  Recruiting at 16 sites Air Force Military Medical University, China · Beijing, Beijing Municipality and 19 other locations · NCT07071441

• Preventing oxygen drops during ERCP with nasal PAP or capnometry

  We'll try whether using nasal positive airway pressure or capnometry with low-flow oxygen during sedated ERCP reduces oxygen drops in adults receiving nurse-administered sedation.

  Recruiting at 2 sites Karl Landsteiner University of Health Sciences · Graz and 1 other locations · NCT07056075

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.